| Year |
Title |
Altmetric |
| 2022
|
CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer.
Oncogene.
41:268-279.
2022
|
|
| 2022
|
Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer.
Oncogene.
2022
|
|
| 2021
|
Anti-cd47 monoclonal antibody–drug conjugate: A targeted therapy to treat triple-negative breast cancers.
Vaccines.
9.
2021
|
|
| 2020
|
Selective Response to Bacterial Infection by Regulating Siglec-E Expression.
iScience.
23.
2020
|
|
| 2020
|
Fibrinogen alpha chain knockout promotes tumor growth and metastasis through integrin-akt signaling pathway in lung cancer
2020
|
|
| 2020
|
A CD24-p53 axis contributes to African American prostate cancer disparities
2020
|
|
| 2019
|
MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.
Oncogene.
38:4820-4834.
2019
|
|
| 2019
|
Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-Myc.
Cancer Research.
79:1413-1425.
2019
|
|
| 2018
|
Bioprocess development of antibody-drug conjugate production for cancer treatment.
PLoS ONE.
13.
2018
|
|
| 2018
|
FOXP3 activates SUMO-conjugating UBC9 gene in MCF7 breast cancer cells.
International Journal of Molecular Sciences.
19.
2018
|
|
| 2018
|
Integrated oncogenomic profiling of copy numbers and gene expression in lung adenocarcinomas without EGFR mutations or ALK fusion.
Journal of Cancer.
9:1096-1105.
2018
|
|
| 2017
|
MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Breast Cancer Research.
19.
2017
|
|
| 2017
|
CD24 is a genetic modifier for risk and progression of prostate cancer.
Molecular Carcinogenesis.
56:641-650.
2017
|
|
| 2017
|
Jun dimerization protein 2 activates Mc2r transcriptional activity: Role of phosphorylation and SUMOylation.
International Journal of Molecular Sciences.
18.
2017
|
|
| 2017
|
MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.
Oncotarget.
8:41451-41464.
2017
|
|
| 2016
|
Rhamnose links moonlighting proteins to membrane phospholipid in mycoplasmas.
PLoS ONE.
11.
2016
|
|
| 2016
|
Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.
Oncotarget.
7:28935-28946.
2016
|
|
| 2016
|
Silencing of CD24 enhances the PRIMA-1-induced restoration of mutant p53 in prostate cancer cells.
Clinical Cancer Research.
22:2545-2554.
2016
|
|
| 2016
|
The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation.
Journal of Cellular Biochemistry.
117:426-438.
2016
|
|
| 2015
|
FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells.
Cancer Research.
75:1703-1713.
2015
|
|
| 2015
|
FOXP3-MIR-146-NF-κB axis and therapy for precancerous lesions in prostate.
Cancer Research.
75:1714-1724.
2015
|
|
| 2015
|
An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation.
Molecular Cell.
57:708-720.
2015
|
|
| 2015
|
Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation.
Nature Communications.
6.
2015
|
|
| 2015
|
A new mitochondrial pool of cyclin E, regulated by Drp1, is linked to cell-density-dependent cell proliferation.
Journal of Cell Science.
128:4171-4182.
2015
|
|
| 2015
|
FOXP3-microRNA-146-NF-κB as oncotarget.
Oncoscience.
2:839-840.
2015
|
|
| 2014
|
SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.
International Journal of Molecular Sciences.
15:10233-10251.
2014
|
|
| 2013
|
Acidic residue Glu199 increases SUMOylation level of nuclear hormone receptor NR5A1.
International Journal of Molecular Sciences.
14:22331-22345.
2013
|
|
| 2012
|
Inactivation of X-linked tumor suppressor genes in human cancer.
Future Oncology.
8:463-481.
2012
|
|
| 2012
|
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
American Journal of Translational Research.
4:347-356.
2012
|
|
| 2011
|
FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1.
Molecular Cell.
44:770-784.
2011
|
|
| 2011
|
Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.
Cancer Research.
71:2162-2171.
2011
|
|
| 2010
|
Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma.
Prenatal Diagnosis.
30:778-782.
2010
|
|
| 2010
|
Prevalence and type distribution of human papillomavirus infection in women from Datong, China.
Scandinavian Journal of Infectious Diseases.
42:72-75.
2010
|
|
| 2010
|
Quantitative detection of the hypermethylated RASSF1A gene in maternal plasma of pre-eclampsia
2010
|
|
| 2010
|
FOXP3 as an X-linked tumor suppressor..
Discovery medicine.
10:322-328.
2010
|
|
| 2009
|
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate.
Cancer Cell.
16:336-346.
2009
|
|
| 2009
|
Pd-CNT-catalyzed ligandless and additive-free heterogeneous Suzuki-Miyaura cross-coupling of arylbromides
2009
|
|
| 2009
|
Asymmetric synthesis of 3-hydroxyl-2-alkanones via tandem organocatalytic aminoxylation of aldehydes and chemoselective diazomethane homologation
2009
|
|
| 2009
|
Stereospecific, flexible and redox-economic asymmetric synthesis of cis- And trans-3-hydroxypipecolic acids and analogs.
European Journal of Organic Chemistry.
2845-2851.
2009
|
|
| 2009
|
F0XP3 Up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.
Cancer Research.
69:2252-2259.
2009
|
|
| 2008
|
Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3β-dependent mechanisms.
Molecular and Cellular Biology.
28:7236-7244.
2008
|
|
| 2008
|
Studies on fluorescence property of Eu3+ dinuclear complexes with 2-thiopheneacetic acid and o-phenanthroline
2008
|
|
| 2008
|
TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species.
Journal of Experimental Medicine.
205:2397-2408.
2008
|
|
| 2008
|
Expression of MCM4 and CDC6 in uterine cervical carcinoma and its relation with HPV16/18 infection
2008
|
|
| 2008
|
Study on relationship between microsatellite alterations of FHIT gene and HPV infection and cervical carcinoma
2008
|
|
| 2008
|
Study on the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma
2008
|
|
| 2007
|
Correlation between the expression of Bcl-2, Survivin and CD44v6 and infection with HPV16/18 in the carcinogenesis of cervical cancer
2007
|
|
| 2007
|
FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Journal of Clinical Investigation.
117:3765-3773.
2007
|
|
| 2007
|
Oral pioglitazone administration increases food intake through ghrelin-independent pathway in Zucker fatty rat.
Diabetes Research and Clinical Practice.
77:351-356.
2007
|
|
| 2007
|
Effect of blockage of costimulatory signal on murine abortion-prone model.
Chinese Medical Journal.
120:1247-1250.
2007
|
|
| 2007
|
A dinucleotide deletion in CD24 confers protection against autoimmune diseases.
PLoS Genetics.
3:0508-0517.
2007
|
|
| 2004
|
The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes.
Journal of Pharmacology and Experimental Therapeutics.
310:52-58.
2004
|
|
| 2003
|
Long-term oral nicotine administration reduces insulin resistance in obese rats
2003
|
|
| 2002
|
Early events involved in the development of insulin resistance in Zucker fatty rat.
International Journal of Obesity.
26:318-326.
2002
|
|
| 2001
|
Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats
2001
|
|
